{
    "2019-08-01": [
        [
            {
                "time": "2023-10-05",
                "original_text": "United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y",
                "features": {
                    "keywords": [
                        "Earnings Beat",
                        "Sales Beat",
                        "Down Y/Y"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "What Should Investors Know About Eli Lilly and Company's (NYSE:LLY) Growth?",
                "features": {
                    "keywords": [
                        "Investors",
                        "Eli Lilly",
                        "Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "FOCUS-Blue-blooded crabs at heart of pharma dispute on drug testing",
                "features": {
                    "keywords": [
                        "Blue-blooded crabs",
                        "pharma dispute",
                        "drug testing"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}